Inpharma Weekly

, Volume 1494, Issue 1, pp 10–10 | Cite as

PEG IFN-α-2b + ribavirin: 12 weeks' worth could do the trick in HCV

Clinical study
  • 4 Downloads

Keywords

Hepatitis Sustained Virological Response Early Response Undetectable Level Duration Group 

Copyright information

© Adis International Ltd 2005

Personalised recommendations